DrugPatentWatch Database Preview
TIBSOVO Drug Profile
When do Tibsovo patents expire, and what generic alternatives are available?
Tibsovo is a drug marketed by Agios Pharms Inc and is included in one NDA. There are three patents protecting this drug.
This drug has forty-three patent family members in twenty-three countries.
The generic ingredient in TIBSOVO is ivosidenib. One supplier is listed for this compound. Additional details are available on the ivosidenib profile page.
Summary for TIBSOVO
International Patents: | 43 |
US Patents: | 3 |
Applicants: | 1 |
NDAs: | 1 |
Suppliers / Packagers: | 1 |
Bulk Api Vendors: | 26 |
Patent Applications: | 5 |
Drug Prices: | Drug price information for TIBSOVO |
DailyMed Link: | TIBSOVO at DailyMed |

Generic Entry Opportunity Date for TIBSOVO
Generic Entry Date for TIBSOVO*:
Constraining patent/regulatory exclusivity:
NDA:
Dosage:
TABLET;ORAL |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
US Patents and Regulatory Information for TIBSOVO
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Agios Pharms Inc | TIBSOVO | ivosidenib | TABLET;ORAL | 211192-001 | Jul 20, 2018 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
Agios Pharms Inc | TIBSOVO | ivosidenib | TABLET;ORAL | 211192-001 | Jul 20, 2018 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
Agios Pharms Inc | TIBSOVO | ivosidenib | TABLET;ORAL | 211192-001 | Jul 20, 2018 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | Y | ➤ Try a Free Trial | ||
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
International Patents for TIBSOVO
Country | Document Number | Estimated Expiration |
---|---|---|
Mexico | 351166 | ➤ Try a Free Trial |
China | 104136411 | ➤ Try a Free Trial |
Chile | 2014001891 | ➤ Try a Free Trial |
Country | Document Number | Estimated Expiration |